Abstract
We modelled and characterised rux resistance in JAK2r B-ALL in vitro to enable development of therapeutic strategies to overcome or avert resistance in these high-risk patients.
Original language | English |
---|---|
Number of pages | 1 |
Publication status | Published - 30 May 2018 |
Externally published | Yes |
Event | Adelaide Protein Group Student Awards 2018 - Adelaide, Australia Duration: 30 May 2018 → … |
Conference
Conference | Adelaide Protein Group Student Awards 2018 |
---|---|
Abbreviated title | APG Student Awards 2018 |
Country/Territory | Australia |
City | Adelaide |
Period | 30/05/18 → … |
Keywords
- Ruxolitinib
- Mutation
- Pro-B Cells
- B-ALL JAK2-fusion